1. Kolyadina I.V., Poddubnaya I.V., Frank G.A., Komov D.V., Karseladze A.I., Ermilova V.D., Vishnevskaya Y.V. Heterogenety of stage I breast cancer: biological and prognostic value. Malignant tumours. 2015; 1: 35–45. (in Russian). doi: 10.18027/2224-5057-2015-1-31-40.
2. Kit O.I.. Shatova Yu.S.. Novikova I.A., Vladimirova L.Yu., Ulianova E.P., Komova E.A., Kechedzhiyeva E.E. P53 and BCL2 expression in different breast cancer subtypes. Fundamental Research. 2014; 10: 85–88. (in Russian).
3. Poddubnaya I.V., Frank G.A., Yagudina R.I., Koroleva N.I., Zavalishina L.E. The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015. Modern Oncology. 2016; 3(18): 19–26. (in Russian).
4. Plotnikova B.E., Nepomnyashchaya E.M., Grigorov C.V. Risk factors for brain metastases in breast cancer. Scientific Statements. Medicine Series. Pharmacy. 2013; 11(154) (22): 84–89. (in Russian).
5. Rossiyskoye obshchestvo klinicheskoy onkologii (RUSSCO). Practical recommendations for the medical treatment of invasive breast cancer. 2018; 113–144. (in Russian).